Ficerasfusp alfa is a tumor‑targeting EGFR/TGF‑beta bifunctional antibody in a registrational Phase III for recurrent/metastatic HPV‑negative head and neck cancer, using a 1,500 mg pivotal dose with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results